Form D · Biotechnology
COFACTOR GENOMICS, INC.
San Francisco, CA · CIK 0001710475
Offering snapshot reported Aug 2, 2023 · SEC filing
- Reported sold
- $1.17M Offering amount: $2M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 20, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 2, 2023 | Initial | $1,174,682 | No comparison | 2 | SEC filing |
| Dec 16, 2021 | Initial | $6,906,712 | No comparison | 9 | SEC filing |
| Jun 28, 2017 | Initial | $10,683,766 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-488603
Source: Form D, filed Aug 2, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jon Armstrong | Director |
| Jarret Glasscock | Director, Executive |
| Jarret Glassock | Director, Executive |
| William Hagstrom | Director |
| John Kuelper | Director, Executive |
| David Messina | Executive |
| Matthew A. Ocko | Director |
| Mark Siegel | Director |
| Armen Vidian | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
300 Brannan St Ste 410
San Francisco, CA, 94107
San Francisco, CA, 94107